Coverage
-
June 22, 2022
Robbins Geller Rudman & Dowd LLP asked Tuesday for a one-third cut of a $15 million settlement that investors won from OvaScience and its venture capital backer Longwood Fund over shareholder losses allegedly caused by misrepresentations about the success of a new fertility treatment.
7 other articles on this case.
View all »